Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

BNB/USDhits a fresh all-time high on positive developments. It hits a high of $855 and is currently trading around $851.50.

About Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. is a diversified company with several divisions, including a cryptocurrency treasury strategy and two promising therapeutic pipelines for ...

Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...

Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...

After expanding into real estate and waste management in its search for new revenue opportunities to boost stock value, ...

Crypto exchange Kraken will custody and manage BNB assets for Windtree Therapeutics' crypto treasury plan tied to Binance ...

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

Windtree said it aims to become the first NASDAQ-listed company to offer direct exposure to BNB. The treasury strategy includes custody, security, and yield generation on BNB tokens, positioning ...

"We are excited to incorporate these new facilities to enable our future BNB acquisitions as part of our BNB treasury strategy," stated Jed Latkin, CEO of Windtree. "Pending stockholder approval, the ...

BNB (BNB) price is down slightly to trade at $771 on Friday, after correcting from its new record high of $809, reached on ...

Windtree Therapeutics, a Nasdaq listed biotechnology company, has plans to raise up to $200 million to build a treasury of ...